Life-threatening, preventable hyperkalemia in a nursing home resident: Case report and literature review

Journal of the American Medical Directors Association

Volumn 6, Issue 6, 2005, Pages 400-405

  Dharmarajan, T S ^a,b,d   Nguyen, Tuan ^b   Russell, Robin O ^a,c  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b OUR LADY OF MERCY MEDICAL CENTER   (United States)

^c Terence Cardinal Cooke Health Care Center   (United States)

^d NONE   (United States)

Author keywords

Drug induced; Hyperkalemia; Long term care; Spironolactone

Indexed keywords

BICARBONATE; CALCIUM; FOLIC ACID; GLUCOSE; INSULIN; MAGNESIUM OXIDE; POLYSTYRENESULFONATE SODIUM; POTASSIUM CHLORIDE; PROPRANOLOL; SPIRONOLACTONE; THIAMINE;

AGED; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; ELECTROCARDIOGRAM; HUMAN; HYPERKALEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; LABORATORY TEST; LETHARGY; MALE; MUSCLE WEAKNESS; NURSING HOME; PHYSICAL EXAMINATION; REVIEW;

EID: 28744437926     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2005.07.006     Document Type: Article

References (20)

1. M.A. Perazella, R.L. Mahnensmith Hyperkalemia in the elderly J Gen Intern Med 12 1997 646 656
2. B.F. Palmer Managing hyperkalemia caused by inhibitors of the renin-angiotensin- aldosterone system N Engl J Med 351 2004 585 592
3. F.J. Gennari Hypokalemia N Engl J Med 339 1998 451 458
4. M. Elisaf, E. Liberopoulos, E. Bairaktari, K. Siamopoulos Hypokalemia in alcoholic patients Drug Alcohol Rev 21 2002 73 76
5. J.M. Rimmer, J.F. Horn, F.J. Gennari Hyperkalemia as a complication of drug therapy Arch Intern Med 147 1987 867 869
6. B.L. Strom, J.L. Carson, R. Schinnar Upper gastrointestinal bleeding from oral potassium chloride comparative risk from microencapsulated vs wax-matrix formulations Arch Intern Med 147 1987 954 957
7. K.T. Weber Aldosterone in congestive failure N Engl J Med 345 2001 1689 1697
8. J.E. Sealey, J.H. Laragh The renin-angiotensin-alsosterone system for normal regulation of blood pressure and sodium and potassium hemostasis J.H. Laragh B.M. Brenner 2nd ed. Hypertension Pathophysiology, Diagnosis and Management Vol 2 1995 Raven Press New York 1763 1796
9. M. Jessup, S. Brozena Heart failure New Engl J Med 348 2003 2007 2018
10. M. Jessup Aldosterone blockade and heart failure N Engl J Med 348 2003 1380 1382
11. B. Pitt, F. Zannad, W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
12. J.J.V. McMurray, E. O'Meara Treatment of heart failure with spironolactone trial and tribulations New Engl J Med 351 2004 526 528
13. B. Pitt In reply. Spironolactone in patients with heart failure N Engl J Med 342 2000 132 134
14. D.N. Juurlink, M.M. Mamdani, D.S. Lee Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study New Engl J Med 351 2004 543 551
15. D.A. Sica, T.W. Gehr, C. Yancy Hyperkalemia, congestive heart failure and aldosterone receptor antagonism Congest Heart Fail 9 4 2003 224 229
16. M. Svensson, F. Gustafsson, S. Galatius Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure retrospective study BMJ 327 2003 1141 1142
17. P. Castellino, D.C. Simonson, R.A. DeFronzo Adrenergic modulation of potassium metabolism during exercise in normal and diabetic humans Am J Physiol 252 1987 E68 E76
18. R.A. DeFronzo Hyperkalemia and hypereninemic hypoaldosteronism Kidney Int 17 1980 118 134
19. S.P. Ponce, A.E. Jennings, N.E. Madias, J.T. Harrington Drug induced hyperkalemia Medicine 64 1985 357 370
20. M.A. Perazella Drug induced hyperkalemia old culprits and new offenders Am J Med 109 2000 307 314